Saga University · Faculty of Medicine · 特任教授

Research keywordsSTAMP阻害剤・NK細胞免疫, KIR and HLA・骨髄異型性症候群 新薬・慢性骨髄性白血病, 無治療寛解維持・慢性骨髄性白血病 幹細胞・多発性骨髄腫 SLAMF7・慢性骨髄性白血病・多発性骨髄腫・NK細胞免疫・骨髄異型性症候群

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Clonal dynamics and therapeutic pressure in myeloproliferative neoplasm with concomitant chronic myeloid leukemia: Potential implications of JAK2-directed therapy and additional mutations2026 · Leukemia
• Long-term outcomes of low-dose dasatinib in older patients with chronic myeloid leukemia in chronic phase: an extended follow-up of the DAVLEC phase 2 trial2026 · Blood Cancer Journal
• Specifically targeting the ABL myristoyl pocket: STAMP inhibitors for chronic myeloid leukemia2026 · Expert Review of Hematology
• Longer-than-expected survival in TP53-mutated MDS with der(5;19)(p10;q10): lessons from three cases2026 · International Journal of Hematology

• 新規DNAメチル化阻害剤を用いたCML幹細胞を標的とした治療戦略2021 · 科学研究費助成事業 若手研究
• KIRアリル多型は慢性骨髄性白血病におけるTKI中止の成功予測因子となり得るのか2019 · 科学研究費助成事業 若手研究

• Official profile
• ORCID